首页> 外国专利> Development of screening method for drugs that improve production of regulatory T cells, and method for producing regulatory T cells using immunosuppressive macrolide antibiotics

Development of screening method for drugs that improve production of regulatory T cells, and method for producing regulatory T cells using immunosuppressive macrolide antibiotics

机译:改善调节性T细胞产生的药物筛选方法的开发以及使用免疫抑制性大环内酯类抗生素产生调节性T细胞的方法

摘要

The present invention provides a method for screening a compound capable of inducing regulatory T cells, comprising the following steps: (1) culturing a CD4 + T cell having a naive phenotype in the presence of a test compound, (2) a step of evaluating the immunosuppressive ability of the T cell isolated in step (1); (3) as a result of the evaluation in step (2), A step of obtaining the test compound as a compound capable of inducing regulatory T cells when the released T cells have immunosuppressive ability. The present invention also provides a method for producing regulatory T cells, comprising culturing CD4 + T cells having a naive phenotype in the presence of a rapamycin compound to obtain regulatory T cells. Regulatory T cells produced by this method are useful as an immunomodulator for the prevention and treatment of organ transplant rejection, allergic diseases, autoimmune diseases, graft-versus-host disease (GVHD), infertility and the like.
机译:本发明提供了一种筛选能够诱导调节性T细胞的化合物的方法,其包括以下步骤:(1)在测试化合物的存在下培养具有幼稚表型的CD4 + T细胞,(2)评估步骤。步骤(1)中分离的T细胞的免疫抑制能力; (3)作为步骤(2)的评估结果,获得当释放的T细胞具有免疫抑制能力时作为能够诱导调节性T细胞的化合物的待测化合物的步骤。本发明还提供了产生调节性T细胞的方法,包括在雷帕霉素化合物的存在下培养具有幼稚表型的CD4 + T细胞以获得调节性T细胞。通过这种方法产生的调节性T细胞可用作免疫调节剂,用于预防和治疗器官移植排斥,过敏性疾病,自身免疫性疾病,移植物抗宿主病(GVHD),不育症等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号